2291. Evaluation of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Patients Receiving Ceftolozane/tazobactam

BACKGROUND: Multidrug-resistant (MDR) Pseudomonas aeruginosa is a challenging pathogen to treat. Ceftolozane/tazobactam (C/T) is a combination cephalosporin and β-lactamase inhibitor that has demonstrated activity against MDR P. aeruginosa, including carbapenem-resistant isolates. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bodo, Emily C, Caffrey, Aisling, Lopes, Vrishali, Cusumano, Jaclyn A, Puzniak, Laura A, McCann, Eilish, LaPlante, Kerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809569/
http://dx.doi.org/10.1093/ofid/ofz360.1969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809569/
http://dx.doi.org/10.1093/ofid/ofz360.1969

Ejemplares similares